Exact Sciences (EXAS)
(Real Time Quote from BATS)
$70.19 USD
-0.64 (-0.90%)
Updated Sep 20, 2024 01:28 PM ET
2-Buy of 5 2
D Value A Growth C Momentum B VGM
Company Summary
Exact Sciences Corporation is a molecular diagnostics company focused on the early detection and prevention of some of the deadliest forms of cancer. The company has developed an accurate, non-invasive, patient-friendly screening test called Cologuard for the early detection of colorectal cancer and pre-cancer.
The company is currently working on the development of additional tests for other types of cancer, with the goal of becoming a leader in cancer screening and diagnostics.
On Nov 8, 2019, Exact Sciences completed the acquisition of Genomic Health for a value of ...
Company Summary
Exact Sciences Corporation is a molecular diagnostics company focused on the early detection and prevention of some of the deadliest forms of cancer. The company has developed an accurate, non-invasive, patient-friendly screening test called Cologuard for the early detection of colorectal cancer and pre-cancer.
The company is currently working on the development of additional tests for other types of cancer, with the goal of becoming a leader in cancer screening and diagnostics.
On Nov 8, 2019, Exact Sciences completed the acquisition of Genomic Health for a value of approximately $2.8 billion. Prior to merger, Genomic Health was a prominent provider of genomic-based diagnostic tests in the field of cancer care. The company used to offer its line of products under the brand name Oncotype DX.
At present, Exact Sciences products and services focus on Screening and Precision Oncology Tests. Within these two segments, Exact Sciences has two of the strongest brands in cancer diagnostics, Cologuard and Oncotype DX respectively.
Screening Tests (74.6% of total revenues in 2023, up 31% from 2022): The company’s Screening tests primarily includes laboratory service revenue from Cologuard tests and PreventionGenetics.
Cologuard Test: The company’s flagship screening product, the Cologuard test, is a patient-friendly, non-invasive stool-based DNA (sDNA) screening test that utilizes a multi-target approach to detect DNA and hemoglobin biomarkers associated with colorectal cancer and pre-cancer.
Precision oncology Tests (25.2% of total revenues in 2023, up 5% from 2022): These tests deliver actionable genomic insights to inform prognosis and cancer treatment after a diagnosis.
Oncotype DX: Genomic Health’s first product, the 21-gene Oncotype DX breast cancer test launched in Jan 2004, is used to predict the likelihood of cancer recurrence, patient survival within 10 years of diagnosis and chemotherapy benefit for early-stage patients.
General Information
Exact Sciences Corporation
5505 ENDEAVOR LANE
MADISON, WI 53719
Phone: 608-535-8815
Fax: 608-284-5701
Web: http://www.exactsciences.com
Email: investorrelations@exactsciences.com
Industry | Medical - Biomedical and Genetics |
Sector | Medical |
Fiscal Year End | December |
Last Reported Quarter | 6/30/2024 |
Exp Earnings Date | 11/6/2024 |
EPS Information
Current Quarter EPS Consensus Estimate | -0.20 |
Current Year EPS Consensus Estimate | -0.95 |
Estimated Long-Term EPS Growth Rate | 37.10 |
Exp Earnings Date | 11/6/2024 |
Price and Volume Information
Zacks Rank | |
Yesterday's Close | 70.83 |
52 Week High | 79.62 |
52 Week Low | 40.62 |
Beta | 1.26 |
20 Day Moving Average | 2,615,985.00 |
Target Price Consensus | 77.55 |
4 Week | 19.93 |
12 Week | 59.20 |
YTD | -4.26 |
4 Week | 16.93 |
12 Week | 52.77 |
YTD | -20.07 |
Shares Outstanding (millions) | 184.77 |
Market Capitalization (millions) | 13,087.25 |
Short Ratio | NA |
Last Split Date | NA |
Dividend Yield | 0.00% |
Annual Dividend | $0.00 |
Payout Ratio | NA |
Change in Payout Ratio | NA |
Last Dividend Payout / Amount | NA / $0.00 |
Fundamental Ratios
P/E (F1) | NA |
Trailing 12 Months | NA |
PEG Ratio | NA |
vs. Previous Year | 80.00% |
vs. Previous Quarter | 82.00% |
vs. Previous Year | 12.41% |
vs. Previous Quarter | 9.68% |
Price/Book | 4.10 |
Price/Cash Flow | 4,158.96 |
Price / Sales | 5.01 |
6/30/24 | -4.97 |
3/31/24 | -7.12 |
12/31/23 | -6.60 |
6/30/24 | -2.41 |
3/31/24 | -3.46 |
12/31/23 | -3.20 |
6/30/24 | 2.17 |
3/31/24 | 1.64 |
12/31/23 | 2.32 |
6/30/24 | 1.98 |
3/31/24 | 1.45 |
12/31/23 | 2.07 |
6/30/24 | -6.00 |
3/31/24 | -8.75 |
12/31/23 | -8.17 |
6/30/24 | -6.70 |
3/31/24 | -9.48 |
12/31/23 | -8.17 |
6/30/24 | -6.59 |
3/31/24 | -9.38 |
12/31/23 | -8.07 |
6/30/24 | 17.28 |
3/31/24 | 17.04 |
12/31/23 | 17.39 |
6/30/24 | 5.43 |
3/31/24 | 5.14 |
12/31/23 | 5.08 |
6/30/24 | 0.73 |
3/31/24 | 0.66 |
12/31/23 | 0.74 |
6/30/24 | 42.07 |
3/31/24 | 39.75 |
12/31/23 | 42.39 |